Discover the triple effects of levosimendan and take a look at the literature supporting its use as a first-line therapy. This drug has different pharmacokinetics from other inotropes, in particular its ability to increase glomerular filtrate rate. Learn more about the rationale for levosimendan use in the pre-, peri- and post-operative period in different patient types and scenarios as Prof. Dr Matthias gives an overview of relevant supporting clinical data.View other expert videos and find out more about the role and potential benefits of levosimendan
Prof. Dr Heringlake explores the need for new therapeutic concepts in high risk CABG patients and the positive effects of preoperative levosimendan in reducing mortality in patients undergoing isolated CABG.
What is known about levosimendan and the kidney? Watch Professor Ricksten as he reviews this question and points out the difference between levosimendan compared to other inotropes.
What makes levosimendan different from other inotropes? Discover the use of levosimendan in different settings, while Dr Herpain explores the benefits of this agent, especially on cardio-renal function.
Are catecholamines safe in critically ill patients? Find out about their negative effects and why it’s time to consider better alternatives.
Prof. Dr Heringlake gives a concise overview of the rationale behind using levosimendan as a first-line agent and runs through the literature suggesting its optimum use. Find out why this drug is not only good for the heart but also good for the kidney.